| Hans-Günter Meyer-Thompson | Cannabis als Medizin
Goods and bads of endocannabinoid system as a therapeutic target:Lessons learned after 30 years.
Goods and bads of endocannabinoid system as a therapeutic target:Lessons learned after 30 years.
Maccarrone M, Di Marzo V, Gertsch J, Grether U, Howlett AC, Hua T, Makriyannis A, Piomelli D, Ueda N, van der Stelt M.
Pharmacol Rev. 2023 May 10:PHARMREV-AR-2022-000600. doi: 10.1124/pharmrev.122.000600. Epub ahead of print. PMID: 37164640.
https://pharmrev.aspetjournals.org/content/early/2023/05/09/pharmrev.122.000600.long